Publikace
- Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib2021 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line2021 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)2021 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Hereditární renální nádorové syndromy2020 | Lékařská fakulta v Plzni
- Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF-III renal cysts: a multicenter study2018 | Lékařská fakulta v Plzni
- Cystic Appearance on Imaging Methods (Bosniak III-IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma2018 | Lékařská fakulta v Plzni
- Morphological Characterization of Papillary Renal Cell Carcinoma Type 1, the Efficiency of Its Surgical Treatment2017 | Lékařská fakulta v Plzni
- Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma2015 | Lékařská fakulta v Plzni
- MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t(6;11)] and Xp11.2 [t(X;1 or X or 17)]2014 | Lékařská fakulta v Plzni
- Tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases2013 | 1. lékařská fakulta, Lékařská fakulta v Plzni
Loading network view...